← Back to Search

T2.coach for Type 2 Diabetes

N/A
Waitlist Available
Led By Olena Mamykina, PhD
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 6 months, 12 months
Awards & highlights

Study Summary

This trial will test a novel approach to personalizing behavioral interventions for self-management of type 2 diabetes, which could be more effective than current methods.

Eligible Conditions
  • Type 2 Diabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 6 months, 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 6 months, 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in HbA1c value
Secondary outcome measures
DPSI Score
DSES Score
PAID Score
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: T2.coachExperimental Treatment1 Intervention
Participants receive standard care (diabetes self-management education provided by their Federally Qualified Community Health Center) and are asked to use T2.coach for 6 months.
Group II: ControlActive Control1 Intervention
Participants receive standard care (diabetes self-management education provided by their Federally Qualified Community Health Center).

Find a Location

Who is running the clinical trial?

University of Colorado, DenverOTHER
1,739 Previous Clinical Trials
2,149,865 Total Patients Enrolled
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,360 Previous Clinical Trials
4,314,572 Total Patients Enrolled
Columbia UniversityLead Sponsor
1,433 Previous Clinical Trials
2,447,529 Total Patients Enrolled

Media Library

T2.coach Clinical Trial Eligibility Overview. Trial Name: NCT04226027 — N/A
Type 2 Diabetes Research Study Groups: Control, T2.coach
Type 2 Diabetes Clinical Trial 2023: T2.coach Highlights & Side Effects. Trial Name: NCT04226027 — N/A
T2.coach 2023 Treatment Timeline for Medical Study. Trial Name: NCT04226027 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is eligibility for this trial restricted to those under 40 or are older individuals also permitted to participate?

"The age requirements for this medical trial stipulate that patients should be between 18 and 65. There are 188 clinical trials specifically designed for individuals under the age of majority, while 968 studies cater to older adults beyond retirement age."

Answered by AI

What is the approximate number of participants for this experiment?

"Affirmative. Clinicaltrials.gov hosts data which corroborates that this medical trial, initially posted on January 17th 2020, is actively recruiting patients. Two sites are currently looking for approximately 280 participants to participate in the study."

Answered by AI

Do I meet the criteria to enlist in this medical experiment?

"This clinical trial is accepting a cohort of 280 individuals with type 2 diabetes mellitus, aged 18 to 65. To participate in the study, patients must additionally meet these requirements: having attended an official health centre-based education program, owning a basic mobile phone."

Answered by AI

Are there any vacancies currently available in this research protocol?

"Indeed, the information posted on clinicaltrials.gov indicates that this medical trial is in the process of enlisting participants. It was originally published on January 17th 2020 and most recently updated April 4th 2022; 280 patients are required to be recruited from two distinct medical sites."

Answered by AI
~53 spots leftby May 2025